Grossmann, Volker - CESifo - 2011
coinsurance rate and stricter price regulations adversely affect R&D spending in the pharmaceutical sector. In contrast, entry … deregulation may lead to quality-improvements of pharmaceuticals, despite reducing price-setting power of pharmaceutical companies …